NCT00642707View on ClinicalTrials.gov

Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
HIV -1 InfectionHIV Infections
Interventions
DRUG

PRO 140 (humanized monoclonal antibody to CCR5)

DRUG

Placebo Comparator

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

Sponsors

Lead Sponsor

CytoDyn, Inc.
All Listed Sponsors
lead

CytoDyn, Inc.

INDUSTRY

NCT00642707 - Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection | Biotech Hunter | Biotech Hunter